Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis-Reply.

Date, Purva S; Choksi, Twinkle; Ingole, Avinash B

Date, Purva S; Choksi, Twinkle; Ingole, Avinash B.

Date PS; Department of Ophthalmology, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, Central Mumbai, Maharashtra, India.
Choksi T; Department of Ophthalmology, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, Central Mumbai, Maharashtra, India.
Ingole AB; Department of Ophthalmology, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, Central Mumbai, Maharashtra, India.

JAMA Ophthalmol ; 140(5): 548-549, 2022 05 01.

Article in English | MEDLINE | ID: covidwho-1777510

Subject(s)

COVID-19; Eye Diseases; Eye Infections, Fungal; Mucormycosis; Orbital Diseases; Antifungal Agents/therapeutic use; Eye Diseases/drug therapy; Eye Infections, Fungal/diagnosis; Eye Infections, Fungal/drug therapy; Humans; Mucormycosis/diagnosis; Mucormycosis/drug therapy; Orbital Diseases/diagnosis; Orbital Diseases/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Orbital Diseases / Eye Infections, Fungal / Eye Diseases / COVID-19 / Mucormycosis Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: JAMA Ophthalmol Year: 2022 Document Type: Article Affiliation country: Jamaophthalmol.2022.0617

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google